e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Sester M., Giehl C., McNerney R., Kampmann B., Walzl G., Cuchí P., Wingfield C., Lange C., Migliori G.B., Kritski A.L., Meyerhans A.
Source:
Eur Respir J 2010; 36: 1242-1247
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sester M., Giehl C., McNerney R., Kampmann B., Walzl G., Cuchí P., Wingfield C., Lange C., Migliori G.B., Kritski A.L., Meyerhans A.. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J 2010; 36: 1242-1247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Clinical management of tuberculosis and HIV-1 co-infection
Source: Eur Respir J 2010; 36: 1460-1481
Year: 2010
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results
Source: Eur Respir J 2011; 38: 1374-1381
Year: 2011
TB drug resistance in high-incidence countries
Source: Eur Respir Mon 2012; 58: 95-110
Year: 2012
Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002
TB situation in Bulgaria – epidemiology, TB-HIV co-infection
Source: Eur Respir J 2006; 28: Suppl. 50, 16s
Year: 2006
TB in children
Source: Eur Respir Mon 2012; 58: 206-218
Year: 2012
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel
Source: Eur Respir J 2008; 32: 413-418
Year: 2008
Current status of fluoroquinolone use for treatment of tuberculosis in Korea
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004
Treatment outcomes of MDR-TB and HIV co-infection in Europe
Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016
Year: 2017
European framework to decrease the burden of TB/HIV
Source: Eur Respir J 2004; 24: 493-501
Year: 2004
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?
Source: Eur Respir J 2011; 38: 1258-1260
Year: 2011
TB in migrants
Source: Eur Respir Mon 2012; 58: 194-205
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept